                         SEQUENCE LISTING

<110>  F. Hoffmann-La Roche AG
       Roche Diagnostics GmbH
       Roche Molecular Systems, Inc.
 
<120>  USE OF PEPTIDOMIMETIC ANTIMICROBIAL PEPTIDES TO LIMIT 
       CROSS-REACTIVITY AND IMPROVE BACTERIAL IDENTIFICATION IN 
       ANTIBIOTIC SUSCEPTIBILITY ASSAYS

<130>  P35570-WO-HS

<150>  US 62/858262
<151>  2019-06-06

<160>  6     

<170>  PatentIn version 3.5

<210>  1
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptidomimetic L8-1


<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  D-Proline

<220>
<221>  MISC_FEATURE
<222>  (14)..(1)
<223>  Loop

<400>  1

Leu Arg Leu Lys Lys Arg Arg Trp Lys Tyr Arg Val Pro Pro 
1               5                   10                  


<210>  2
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptidomimetic L19-45


<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  D-Proline

<220>
<221>  MISC_FEATURE
<222>  (14)..(1)
<223>  Loop

<400>  2

Arg Trp Leu Lys Lys Arg Arg Trp Lys Tyr Tyr Val Pro Pro 
1               5                   10                  


<210>  3
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptidomimetic L26-19


<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  D-Proline

<220>
<221>  MISC_FEATURE
<222>  (14)..(1)
<223>  loop

<400>  3

Thr Trp Leu Lys Lys Arg Arg Trp Lys Lys Val Lys Pro Pro 
1               5                   10                  


<210>  4
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptidomimetic L27-11


<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  D-Proline

<220>
<221>  MISC_FEATURE
<222>  (14)..(1)
<223>  loop

<400>  4

Thr Trp Leu Lys Lys Arg Arg Trp Lys Lys Ala Lys Pro Pro 
1               5                   10                  


<210>  5
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptidomimetic POL7001


<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  Dbu

<220>
<221>  MOD_RES
<222>  (6)..(7)
<223>  Dbu

<220>
<221>  MOD_RES
<222>  (9)..(10)
<223>  Dbu

<220>
<221>  MOD_RES
<222>  (12)..(12)
<223>  Dbu

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  D-Proline

<220>
<221>  MISC_FEATURE
<222>  (14)..(1)
<223>  loop

<400>  5

Thr Trp Ile Xaa Lys Xaa Xaa Trp Xaa Xaa Ala Xaa Pro Pro 
1               5                   10                  


<210>  6
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptidomimetic POL7800


<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  Dbu

<220>
<221>  MOD_RES
<222>  (5)..(5)
<223>  Orn

<220>
<221>  MOD_RES
<222>  (6)..(7)
<223>  Dbu

<220>
<221>  MOD_RES
<222>  (9)..(10)
<223>  Dbu

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  D-Proline

<220>
<221>  MISC_FEATURE
<222>  (14)..(1)
<223>  loop

<400>  6

Thr Trp Ile Xaa Xaa Xaa Xaa Trp Xaa Xaa Ala Ser Pro Pro 
1               5                   10                  


